CO

Co-Diagnostics

- NASDAQ:CODX
Last Updated 2024-04-16

LinkedIn Profile

Access Co-Diagnostics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:codx 3706029 Apr 14th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 13th, 2024 10:49PM Apr 13th, 2024 10:49PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 13th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 12th, 2024 10:40PM Apr 13th, 2024 11:15AM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 12th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 11th, 2024 10:44PM Apr 12th, 2024 08:10AM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 11th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 10th, 2024 11:17PM Apr 11th, 2024 10:55AM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 10th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 9th, 2024 10:48PM Apr 10th, 2024 05:03PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 9th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 8th, 2024 10:59PM Apr 9th, 2024 09:45AM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 8th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 7th, 2024 11:25PM Apr 8th, 2024 06:43PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 7th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 114.00 Open Apr 6th, 2024 10:55PM Apr 6th, 2024 10:55PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 6th, 2024 12:00AM Co-Diagnostics, Inc 3.2K 115.00 Open Apr 5th, 2024 10:55PM Apr 5th, 2024 10:55PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics
nasdaq:codx 3706029 Apr 5th, 2024 12:00AM Co-Diagnostics, Inc 3.1K 115.00 Open Apr 4th, 2024 11:22PM Apr 4th, 2024 11:22PM MISSION STATEMENT Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics, to transform healthcare delivery and to create a positive impact on a global scale by enabling availability of robust, high-quality, affordable polymerase chain reaction (“PCR”) technology—especially to regions of the world where the need is greatest. Our patented Co-Primers™ technology is paving the way for innovation in disease detection and life sciences research, while we are preparing to launch an innovative at-home and point-of-care real-time PCR testing platform. The purpose of the new Co-Dx PCR Pro™ instrument and tests is to make high-quality real-time PCR diagnostics (the gold-standard of infectious disease testing) widely accessible where it is needed most, including in remote areas, at the point-of-care or even at home, all at affordable prices. Open Molecular Diagnostics, DNA Testing, Polymerase Chain Reaction, PCR, Primer Design, Infectious Disease, NGS, and POCT Open 2401 S Foothill Dr Salt Lake City Utah US Co-Diagnostics

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.